[1] Wu J, Dai FJ, Li Ch, et al. Gender differences in cardiac hypertrophy[J]. J Cardiovasc Transl Res, 2020, 13(1): 73-84.
[2] Xin KY, Ma LL, Dong Zh, et al. Mitochondrial proteomics in myocardial hypertrophic preconditioning mice [J]. Acta Anatomica Sinica, 2020, 51(3): 378-384. (in Chinese)
辛凯悦,马雷雷,董震,等.心肌肥厚预适应小鼠线粒体蛋白质组学分析[J].解剖学报,2020,51(3):378-384.
[3] Tang LQ, Yu XQ, Zheng YY, et al. Inhibiting SLC26A4 reverses cardiac hypertrophy in H9C2 cells and in rats[J]. Peer J, 2020, 8(5): e8253.
[4] Mulder N, Scheartz R, Brazas MD, et al. The development and application of bioinformatics core competencies to improve bioinformatics training and education[J]. PLoS Comput Biol, 2018, 14(2): e1005772.
[5] Grossman W, Paulus WJ. Myocardial stress and hypertrophy:a complex interface between biophysics and cardiac remodeling[J]. J Clin Invest, 2013, 123(9): 3701-3703.
[6] Yan W, Wang P, Zhao CX, et al. Decorin gene delivery inhibits cardiac fibrosis in spontaneously hypertensive Rats by modulation of transforming growth factor-β/Smad and p38 mitogen-activated protein kinase signaling pathways[J]. Hum Gene Ther, 2009, 20(10): 1190-1200.
[7] Hu H, Li P, Cheng XSh. Research progress of mitochondrial dysfunction and cardiac hypertrophy[J]. Chongqing Medicine, 2018, 47(23): 3081-3083. (in Chinese)
胡欢,李萍,程晓曙.线粒体功能障碍与心肌肥厚的研究进展[J].重庆医学,2018,47(23):3081-3083.
[8] J?rvinen TAH, Ruoslahti E. Generation of a multi-functional, target organ-specific, anti-fibrotic molecule by molecular engineering of the extracellular matrix protein, decorin[J]. Br J Pharmacol, 2019, 176(1): 16-25.
[9] Barreiro JB, Gupta S, Zoccarato A, et al. Glycoproteomics reveals decorin peptides with anti-myostatin activity in human atrial fibrillation[J]. Circulation, 2016, 134(11): 817-832.
[10] Nagao K, Inada T, Tamura A, et al. Circulating markers of collagen typesⅠ, Ⅲ, and Ⅳ in patients with dilated cardiomyopathy: relationships with myocardial collagen expression[J]. ESC Heart Fail, 2018, 5(6): 1044-1051.
[11] Wang Q, OKA T, Yamagami K, et al. An EP4 receptor agonist inhibits cardiac fibrosis through activation of PKA signaling in hypertrophied heart[J]. Int Heart J, 2016, 58(1): 107-114.
[12] Denigris J, Yao Q, Birk EK, et al. Altered dermal fibroblast behavior in a collagen Ⅴ haploinsufficient murine model of classic Ehlers-Danlos syndrome[J]. Connect Tissue Res, 2015, 57(1): 1-9.
[13] Tae HJ, Petrashevskaya N, Marshall S, et al. Cardiac remodeling in the mouse model of Marfan syndrome develops into two distinctive phenotypes[J]. Am J Physiol Heart Circ Physiol, 2016, 310(2): H290-H299.
[14] Xiao X, Wang W, Li YQ, et al. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma[J]. J Exp Clin Cancer Res, 2018, 37(1): 201-213.
[15] Huang HCh, Li Y, Wei WF, et al. Effects of rosuvastatin combined with irbesartan on MAPK/ERK and JNK pathways in rats with myocardial hypertrophy[J]. Journal of Clinical and Experimental Medicine, 2018, 272(16): 1703-1708. (in Chinese)
黄宏超,李阳,魏文峰,等.瑞舒伐他汀联合厄贝沙坦对心肌肥厚大鼠MAPK/ERK和JNK通路的影响[J].临床和实验医学杂志,2018,17(16):1703-1708.
[16] García R, Merino D, Gómez JM, et al. Extracellular heat shock protein 90 binding to TGFβ receptor Ⅰ participates in TGFβ-mediated collagen production in myocardial fibroblasts[J]. Cell Signal, 2016, 28(10): 1563-1579.
[17] Maeyashiki C, Oshima S, Otsubo K, et al. HADHA, the alpha subunit of the mitochondrial trifunctional protein, is involved in long-chain fatty acid-induced autophagy in intestinal epithelial cells[J]. Biochem Biophys Res Commun, 2017, 484(3): 636-641.
|